Search Page

1

Cite

Share

Fibroblast growth factor signaling in non-small-cell lung cancer.

Semrad TJ, Mack PC. Semrad TJ, et al. Clin Lung Cancer. 2012 Mar;13(2):90-5. doi: 10.1016/j.cllc.2011.08.001. Epub 2011 Sep 29. Clin Lung Cancer. 2012. PMID: 21959109 Review.

Cite

Share

2

Cite

Share

Geographic variation of racial/ethnic disparities in colorectal cancer testing among medicare enrollees.

Semrad TJ, Tancredi DJ, Baldwin LM, Green P, Fenton JJ. Semrad TJ, et al. Cancer. 2011 Apr 15;117(8):1755-63. doi: 10.1002/cncr.25668. Epub 2011 Jan 10. Cancer. 2011. PMID: 21472723 Free PMC article.

Cite

Share

3

Cite

Share

Feasibility study of intra-patient sorafenib dose-escalation or re-escalation in patients with previously treated advanced solid tumors.

Semrad TJ, Eddings C, Pan CX, Lau DH, Gandara D, Beckett L, Lara PN Jr. Semrad TJ, et al. Invest New Drugs. 2012 Oct;30(5):2001-7. doi: 10.1007/s10637-011-9761-y. Epub 2011 Oct 21. Invest New Drugs. 2012. PMID: 22015991 Free PMC article. Clinical Trial.

Cite

Share

4

Cite

Share

Phase I study of the combination of temsirolimus and pazopanib in advanced solid tumors.

Semrad TJ, Eddings C, Dutia MP, Christensen S, Lara PN Jr. Semrad TJ, et al. Anticancer Drugs. 2013 Jul;24(6):636-40. doi: 10.1097/CAD.0b013e3283618b7b. Anticancer Drugs. 2013. PMID: 23698253 Free PMC article. Clinical Trial.

Cite

Share

5

Cite

Share

Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results.

Semrad T, Barzi A, Lenz HJ, Hutchins IM, Kim EJ, Gong IY, Tanaka M, Beckett L, Holland W, Burich RA, Snyder-Solis L, Mack P, Lara PN Jr. Semrad T, et al. Int J Clin Oncol. 2015 Jun;20(3):518-24. doi: 10.1007/s10147-014-0730-2. Epub 2014 Aug 5. Int J Clin Oncol. 2015. PMID: 25091263 Free PMC article.

Cite

Share

6

Cite

Share

Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials.

Lara PN Jr, Moon J, Redman MW, Semrad TJ, Kelly K, Allen JW, Gitlitz BJ, Mack PC, Gandara DR. Lara PN Jr, et al. Among authors: semrad tj. J Thorac Oncol. 2015 Jan;10(1):110-5. doi: 10.1097/JTO.0000000000000385. J Thorac Oncol. 2015. PMID: 25490004 Free PMC article. Clinical Trial.

Cite

Share

7

Cite

Share

Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.

Tomlinson BK, Thomson JA, Bomalaski JS, Diaz M, Akande T, Mahaffey N, Li T, Dutia MP, Kelly K, Gong IY, Semrad T, Gandara DR, Pan CX, Lara PN Jr. Tomlinson BK, et al. Clin Cancer Res. 2015 Jun 1;21(11):2480-6. doi: 10.1158/1078-0432.CCR-14-2610. Epub 2015 Mar 4. Clin Cancer Res. 2015. PMID: 25739672 Free PMC article. Clinical Trial.

Cite

Share

8

Cite

Share

Initial treatment patterns in younger adult patients with differentiated thyroid cancer in California.

Semrad TJ, Semrad AM, Farwell DG, Chen Y, Cress R. Semrad TJ, et al. Among authors: semrad am. Thyroid. 2015 May;25(5):509-13. doi: 10.1089/thy.2014.0610. Epub 2015 Mar 23. Thyroid. 2015. PMID: 25744759 Free PMC article.

Cite

Share

9

Cite

Share

Phase II clinical trials on investigational drugs for the treatment of pancreatic cancers.

Kim EJ, Semrad TJ, Bold RJ. Kim EJ, et al. Among authors: semrad tj. Expert Opin Investig Drugs. 2015 Jun;24(6):781-94. doi: 10.1517/13543784.2015.1026963. Epub 2015 Mar 25. Expert Opin Investig Drugs. 2015. PMID: 25809274 Free PMC article. Review.

Cite

Share

10

Cite

Share

Integrating Chemotherapy into the Management of Oligometastatic Colorectal Cancer: Evidence-Based Approach Using Clinical Trial Findings.

Semrad TJ, Fahrni AR, Gong IY, Khatri VP. Semrad TJ, et al. Ann Surg Oncol. 2015 Dec;22 Suppl 3(0 3):S855-62. doi: 10.1245/s10434-015-4610-4. Epub 2015 Jun 23. Ann Surg Oncol. 2015. PMID: 26100816 Free PMC article.

Cite

Share